|
LanoxinDrug - Lanoxin The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Digoxin
Strength -
0.1875MG
Applicant -
SMITHKLINE BEECHAM
New Drug Application (NDA) Number -
020405
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Sep 30, 1997
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Smithkline Beecham Corp Dba Glaxosmithkline
Lanoxin
Digoxin 0.25mg Tablet; Oral
Digoxin 0.125mg Tablet; Oral Digoxin 0.25mg Tablet; Oral Digoxin 0.125mg Tablet; Oral Digoxin 0.25mg Tablet; Oral Lanoxin 0.0625mg Tablet; Oral Lanoxin 0.125mg Tablet; Oral Lanoxin 0.1875mg Tablet; Oral Lanoxin Pediatric 0.1mg/ml Injectable; Injection Digoxin 0.125mg Tablet; Oral NewDrugInformation |